The Cost-Effectiveness of Birth Cohort Screening for Hepatitis C Antibody in US Primary Care Settings
Authors:
- Raj VuppalanchiRVRaj Vuppalanchi
- Paul Y. KwoPKPaul Y. Kwo
- 1 February 2013
- journal article
- editorial
- Published by Elsevier in Gastroenterology
- Vol. 144 (2) , 457-459
Abstract
No abstract availableFunding Information
- Bristol-Myers Squibb Canada
- Merck
- Bayer Fund
- Novartis
- Roche Diagnostics
- Abbott Fund
- Gilead Sciences